Innovation is in our DNA.
Advancing specialty therapies to improve patients’ health.

Hematology

Hematology encompasses complex diseases affecting the blood and the organs responsible for its production, with a significant impact across the region. At ELEA EXELTIS, we work on therapeutic solutions for hematological conditions that require a high level of specialization, providing options aimed at strengthening clinical management across the different markets where we operate.

BRAND NAME ACTIVE INGREDIENT INDICATION COMMERCIALIZATION
Gesnat
Eltrombopag

Treatment of chronic ITP and severe aplastic anemia in patients with an insufficient response to prior therapy.

Ecuador Peru Centroamerica Venezuela

Gesnat

Eltrombopag


Treatment of chronic ITP and severe aplastic anemia in patients with an insufficient response to prior therapy.


Ecuador Peru Centroamerica Venezuela